/
We are a microbiome technology company with a portfolio of intellectual property and microbiome assets. Our objectives are to realize the value of our intellectual property estate through licensing our technology to collaboration partners and enforcing our patent rights against infringing parties through intellectual property litigation and, in certain cases, to generate additional data on sele…
$7.92
+$0.02 (+0.22%)
Price from 19 days ago
The business is unprofitable at the operating level (-78374.77% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 87.6% YoY. Margins deteriorated 64949.3pp alongside, both lines moving the wrong way.
ROIC dropped from -51.26% to -65.90%, capital efficiency is deteriorating. Negative free cash flow of -$32M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
▼ -87.6% YoY
Net Income (TTM)
-$14M
▲ +34.8% YoY
Op. Margin
-78374.77%
▼ -64949.3pp YoY
ROIC
-30.60%
▼ -14.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$18M
▲ +59.1% YoY
Op. Cash Flow (TTM)
-$18M
▲ +57.9% YoY
Net Debt
$13M
Cash & Equiv.
$16M
3Y CAGR: -76.0%
Continue Research